|
| |
Overview
Financial Highlight
HeadlinesBusiness Background Bintai Kinden Corp Bhd is a Malaysian investment holding company. Its business activities are specialized mechanical and electrical engineering services and environment and facilities management services; undertake turnkey, infrastructure, civil and structural construction project; and trading in building materials. Its other business practices are property development of residential properties; concession arrangements in the construction and maintenance of facilities and infrastructure; and investment holding in quoted and unquoted shares and other investment-related activities. The majority of the company’s revenue comes from Singapore.
  ammar97 so bintai get related to vaccine is fake news? since the price is dropping drastically... 17/01/2021 11:37 AM  FortuneBlooming Something fishy: Pfizer CEO not jabbing himself with Pfizer vaccine raises big questions https://www.news18.com/amp/news/buzz/something-fishy-pfizer-ceo-not-getting-his-own-companys-covid-19-vaccine-raises-questions-3182408.html 17/01/2021 10:36 PM bigby7 China Vaccine 50% effective.. Now pfizer deaths..From 23 to 29 now Scary oh.. Esok Bintai mau turun to 0.5sen again :( https://www.bloomberg.com/news/articles/2021-01-16/norway-vaccine-fata... 18/01/2021 12:13 AM B4b4 Bintai will soon be a vaccine stock. Bintai Healthcare will be selling The Complete Vaccine in Malaysia and ASEAN countries. 18/01/2021 9:42 AM stainlyho37 strong feel that to be Theme play again later today...watch out...BIntai, Solutn !!!! 18/01/2021 9:46 AM birdparadise Hahaha tengok siapa boleh tàhan, relax lah takut apa ,baby don't cry,enjoy i punya coffee, Wakaka. 18/01/2021 10:30 AM ask1961 KUALA LUMPUR (Jan 8): A subsidiary of Bintai Kinden Corp Bhd has been appointed the exclusive distributor for the Greenie Medi Cold Chain Box designed for the storage and distribution of Covid-19 vaccines in Malaysia. The subsidiary, Bintai Healthcare Sdn Bhd, has also been appointed an authorised distributor for the product in Southeast Asian countries. In a statement today, the company, whose share price has risen 4.5 times over the past five months, said Bintai Healthcare today signed a distribution agreement with South Korea’s SLAB Asia Co Ltd to distribute the full range of Greenie Medi Cold Chain Box products in Malaysia, Brunei, Myanmar, Cambodia, Timor-Leste, Indonesia, Laos, the Philippines, Singapore, Thailand and Vietnam. The Greenie Medi Cold Chain Box was designed for the exclusive use in transporting and storing medical products at very low temperatures as it keeps the inbox temperature at -70℃ for up to 120 hours. SLAB Asia operates South Korea’s only ISTA 7D/7E certified private test lab which offers its customers internationally recognised quality assurance. Notably, ISTA 7D/7E is a test standard set by the Center for Drug Evaluation and Research under the US Food and Drug Administration (FDA) in certifying compatibility and adequacy for transporting medical-grade products. “We are here to support the government’s initiatives in vaccine distribution, and to complement the existing cold chain infrastructure and provide comprehensive solutions to meet critical needs in times like these, and to support needs for Covid-19 vaccine distribution,” said Bintai Kinden group managing director Ong Choon Lui. “The Greenie Medi Cold Chain Box is the ideal solution for getting temperature-sensitive drugs, biologics and vaccines safely to end users across Malaysia and beyond,” he added. This agreement is expected to contribute positively towards the group’s future earnings. It was in October of last year when Bintai Kinden ventured into distribution of Covid-19 vaccines. Bintai Healthcare was granted the exclusive rights from Generex Biotechnology Corp and its subsidiary NuGenerex Immuno-Oncology Inc to distribute, sell and commercialise Covid-19 vaccines in Malaysia, Brunei, Myanmar, Cambodia, Timor-Leste, Indonesia, Laos, the Philippines, Singapore, Thailand and Vietnam. It has also been given the first right of refusal to distribute and market the vaccine within Australia, New Zealand and the global halal market. While Bintai Kinden has fallen from its 16-year peak of RM1.39 a month ago, it was still up 1.72% or one sen at 59 sen at the midday break today, valuing it at RM225.32 million. 18/01/2021 10:44 AM ask1961 Read d above news. Latest Bintai is doing distribution business. Nothing 2 do with western vacc which got alot of -ve news. 18/01/2021 10:46 AM ask1961 Pls rmmber. Downed from 139 to 56 ALOT OF DISCOUNT AREADY LO. LGI MAU DISCOUNT AA. BUY UNDERWARE LO. 18/01/2021 10:56 AM SurpriseOne GNBT - Generex Biotechnology Corporation Other OTC - Other OTC Delayed Price. Currency in USD 0.2867 -0.0200 (-6.52%)At close: January 15 3:59PM EST 18/01/2021 1:11 PM Ahead1268 Seller dried out. Time to buy When go up. Do not buy. Wait for right timing only sell. 18/01/2021 1:46 PM B4b4 On 7 Oct 2020, Bintai has paid NGIO, a subsidiary of Generex, USD 2.625 m for the licensing fee of li-Key Sars-Covid19 vaccine. 18/01/2021 3:00 PM B4b4 Bintai will provide 100% funding for US clinical development, manufacturing and commercial registration of li-Key-Sars-Cov-2 prophylactic vaccine against Covid19 in international markets 18/01/2021 3:05 PM  | |
